Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

Background. Patients afflicted with Alzheimer's disease (AD) exhibit a decrease in the cerebrospinal fluid (CSF) concentration of the 42 amino acid form of β-amyloid (Aβ42). However, a high discrepancy between different centers in measured Aβ42 levels reduces the utility of this biomarker as a...

Full description

Bibliographic Details
Main Authors:	Maria Bjerke, Erik Portelius, Lennart Minthon, Anders Wallin, Henrik Anckarsäter, Rolf Anckarsäter, Niels Andreasen, Henrik Zetterberg, Ulf Andreasson, Kaj Blennow
Format:	Article
Language:	English
Published:	Hindawi Limited 2010-01-01
Series:	International Journal of Alzheimer's Disease
Online Access:	http://dx.doi.org/10.4061/2010/986310

Similar Items

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
by: Mikko Hölttä, et al.
Published: (2013-01-01)

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
by: Anckarsäter Henrik, et al.
Published: (2010-06-01)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
by: Bromander Sara, et al.
Published: (2012-10-01)

<it>BACE1 </it>gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
by: Minthon Lennart, et al.
Published: (2010-09-01)

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
by: Pei‐Ning Wang, et al.
Published: (2020-01-01)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Annika Öhrfelt, et al.
Published: (2016-07-01)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
by: Rosengren Lars, et al.
Published: (2009-12-01)

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
by: Per Johansson, et al.
Published: (2017-01-01)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
by: Niels Andreasen, et al.
Published: (2010-01-01)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
by: Christoffer Rosén, et al.
Published: (2014-07-01)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
by: Henrik Zetterberg, et al.
Published: (2010-01-01)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Ulf Andreasson, et al.
Published: (2016-01-01)

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and <it>PSEN1 </it>A431E-associated familial Alzheimer's disease
by: Galasko Douglas, et al.
Published: (2010-01-01)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
by: Peder Buchhave, et al.
Published: (2009-01-01)

Ubiquitin carboxy-terminal hydrolase L1 <it>(UCHL1) </it>S18Y polymorphism in Alzheimer's disease
by: Andreasen Niels, et al.
Published: (2010-03-01)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
by: Karolina Minta, et al.
Published: (2020-10-01)

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.
by: Niklas Mattsson, et al.
Published: (2012-01-01)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.
Published: (2013-01-01)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
by: Bremell Daniel, et al.
Published: (2013-01-01)

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Clara Hjalmarsson, et al.
Published: (2014-05-01)

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
by: Clara Hjalmarsson, et al.
Published: (2014-01-01)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
by: Ezra Mulugeta, et al.
Published: (2011-01-01)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
by: Lovisa Tobieson, et al.
Published: (2021-08-01)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
by: Karolina Minta, et al.
Published: (2021-05-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-12-01)

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
by: Ronald Lautner, et al.
Published: (2017-10-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
by: Mikko Hölttä, et al.
Published: (2012-01-01)

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
by: Valter Niemelä, et al.
Published: (2018-01-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments.
by: Marianne K O Grant, et al.
Published: (2019-01-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01)

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
by: Marie Eckerström, et al.
Published: (2020-12-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
by: María-Salud García-Ayllón, et al.
Published: (2017-05-01)

Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer’s Disease
by: Philip W. Brownjohn, et al.
Published: (2017-04-01)

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
by: Bruno Becker, et al.
Published: (2018-08-01)

Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
by: Ulrika Andersson-Hall, et al.
Published: (2021-01-01)

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS
by: Maria Blomqvist, et al.
Published: (2017-07-01)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
by: Nina Schultz, et al.
Published: (2019-01-01)